ArticleNature communications2023

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.

Peng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.